CTRI/2017/11/010353
Completed
未知
Safety and efficacy of Dexmedetomidine for procedural sedation during combined laparoscopic interval tubal ligation and medical termination of pregnancy- a randomized, controlled, double-blinded trial
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- FEMALE PATIENTS SCHEDULED FOR LAPAROSCOPIC TUBAL LIGATION WITH MEDICAL TERMINATION OF PREGNANCY
- Sponsor
- ALL INDIA INSTITUTE OF MEDICAL SCIENCES
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients(ASA I and II) scheduled for laparoscopic interval tubal ligation with MTP under local anesthesia(procedure time 15 TO 30 minutes)
Exclusion Criteria
- •1\. Not willing to participate
- •2\. patient having local anesthetic hypersensitivity
- •3\. patients With uncontrolled co morbid condition
- •4\. Inadequate fasting
- •concurrent surgeries
- •difficult airway
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Efficacy and Safety of use of Dexmedetomidine for Hypotensive Anaesthesia in Patients undergoing Functional Endoscopic sinus surgeryCTRI/2024/07/070582Dr Sridevi Mulimani
Completed
Not Applicable
Patient safety and satisfaction with dexmedetomidine sedation during endoscopic oesophageal interventionsISRCTN68599804Academic Medical Centre (AMC) (Netherlands)64
Completed
Phase 3
Safety and Effectiveness using DEXmedetomidine sedation versus Propofol/Alfentanil sedation during oesophagus interventions. (SEDEX)NL-OMON35831Academisch Medisch Centrum64
Completed
Phase 4
A clinical study to find whether dexmedetomidine provides adequate comfort to patients during awake nasal fibreoptic intubatioHealth Condition 1: null- Scheduled for awake nasal fibreoptic intubation in view of assessed difficult airwayCTRI/2012/09/002948Kasturba Hospital KMC Manipal36
Recruiting
Phase 3
Evaluation of the effectiveness of dexmedetomidineine sedation of COVID-19 critically ill patientsIRCT20110425006280N13Vice President of Research Guilan university of medical sciences60